Federation Des Caisses Desjardins Du Quebec Acasti Pharma Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 14, 2024
SELL
$0.52 - $2.95 $93 - $528
-179 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$0.43 - $0.57 $2 - $3
-6 Reduced 3.24%
179 $94,000
Q3 2022

Aug 14, 2024
SELL
$0.62 - $3.66 $27 - $164
-45 Reduced 19.57%
185 $101,000
Q1 2022

Aug 14, 2024
BUY
$0.94 - $1.43 $216 - $328
230 New
230 $276,000
Q3 2021

Aug 30, 2024
BUY
$1.96 - $4.72 $450 - $1,085
230 New
230 $449,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $145M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email